127 related articles for article (PubMed ID: 17400606)
1. Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting.
Tiroch K; Koch W; von Beckerath N; Kastrati A; Schömig A
Eur Heart J; 2007 Apr; 28(8):968-73. PubMed ID: 17400606
[TBL] [Abstract][Full Text] [Related]
2. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
[TBL] [Abstract][Full Text] [Related]
3. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting.
Chen YH; Chau LY; Lin MW; Chen LC; Yo MH; Chen JW; Lin SJ
Eur Heart J; 2004 Jan; 25(1):39-47. PubMed ID: 14683741
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor.
Schillinger M; Exner M; Minar E; Mlekusch W; Müllner M; Mannhalter C; Bach FH; Wagner O
J Am Coll Cardiol; 2004 Mar; 43(6):950-7. PubMed ID: 15028349
[TBL] [Abstract][Full Text] [Related]
5. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A
Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptors gene polymorphisms and risk of restenosis and clinical events following coronary stenting.
Neugebauer P; Goldbergová-Pávková M; Kala P; Bocek O; Jerábek P; Poloczek M; Vytiska M; Parenica J; Mikulík R; Jarkovský J; Semrád B; Spinar J; Vasků A
Vnitr Lek; 2009 Dec; 55(12):1135-40. PubMed ID: 20070029
[TBL] [Abstract][Full Text] [Related]
7. Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.
Gulesserian T; Wenzel C; Endler G; Sunder-Plassmann R; Marsik C; Mannhalter C; Iordanova N; Gyöngyösi M; Wojta J; Mustafa S; Wagner O; Huber K
Clin Chem; 2005 Sep; 51(9):1661-5. PubMed ID: 16020495
[TBL] [Abstract][Full Text] [Related]
8. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
Hoppmann P; Koch W; Schömig A; Kastrati A
Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting.
Tiroch K; von Beckerath N; Koch W; Lengdobler J; Joost A; Schömig A; Kastrati A
Atherosclerosis; 2005 Sep; 182(1):145-51. PubMed ID: 16115485
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis.
Zhang MM; Zheng YY; Gao Y; Zhang JZ; Liu F; Yang YN; Li XM; Ma YT; Xie X
Oncotarget; 2016 Dec; 7(50):83437-83450. PubMed ID: 27825138
[TBL] [Abstract][Full Text] [Related]
11. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
Chiou KR; Chung SL; Charng MJ
J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
[TBL] [Abstract][Full Text] [Related]
12. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
[TBL] [Abstract][Full Text] [Related]
13. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan.
Wu MM; Chiou HY; Chen CL; Wang YH; Hsieh YC; Lien LM; Lee TC; Chen CJ
Toxicol Appl Pharmacol; 2010 Nov; 248(3):226-33. PubMed ID: 20708634
[TBL] [Abstract][Full Text] [Related]
14. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
Pesonen U; Koch W; Schömig A; Kastrati A
J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP
J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748
[TBL] [Abstract][Full Text] [Related]
16. The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.
Fragoso JM; Zuñiga-Ramos J; Arellano-González M; Alvarez-León E; Villegas-Torres BE; Cruz-Lagunas A; Delgadillo-Rodriguez H; Peña-Duque MA; Martínez-Ríos MA; Vargas-Alarcón G
Exp Mol Pathol; 2015 Feb; 98(1):13-7. PubMed ID: 25449332
[TBL] [Abstract][Full Text] [Related]
17. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
18. Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.
Koch W; Böttiger C; Mehilli J; von Beckerath N; Neumann FJ; Schömig A; Kastrati A
Am J Cardiol; 2001 Nov; 88(10):1120-4. PubMed ID: 11703955
[TBL] [Abstract][Full Text] [Related]
19. Provisional stenting for multivessel PCI.
Han B; Liu L; Aboud M; Nahir M; Hasin Y
Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
Koch W; Ndrepepa G; Mehilli J; Braun S; Burghartz M; Lengnick H; Kölling K; Schömig A; Kastrati A
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2229-34. PubMed ID: 14604831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
